Journals / Ankara Medical Journal / 2016 / Cilt: 16 - Sayı: 4

Effect of Positive Airway Pressure Treatment on the Life Quality of Patients with Sleep Apnea Syndrome

Uyku Apne Sendromu Hastalarında Pozitif Hava Yolu Basıncı Tedavisinin Yaşam Kalitesi Üzerine Etkisi

Pages
347–353
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Results: Appropriate use of PAP devices improved quality of life as evidenced by improvement on allparameters of the SF‐36 instrument quality‐of‐life scale (P

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: Sleep apnea syndrome (OSA) is closely associated with obesity and cardiovascular diseases.OSA disrupts neurocognitive functioning and negatively affects quality of life.
📊
Key Findings & Data:We used the Short Form‐36 (SF‐36)instrument to measure quality‐of‐life changes in PAP‐treated patients in Turkey.Materials and Methods: The present study included 67 (52 male) consecutive OSA patients treated witha PAP device.
💡
Conclusion & Impact:Results: Appropriate use of PAP devices improved quality of life as evidenced by improvement on allparameters of the SF‐36 instrument quality‐of‐life scale (P
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objectives: Sleep apnea syndrome (OSA) is closely associated with obesity and cardiovascular diseases.OSA disrupts neurocognitive functioning and negatively affects quality of life. Use of a positive airwaypressure (PAP) device remains the gold standard treatment for OSA. We used the Short Form‐36 (SF‐36)instrument to measure quality‐of‐life changes in PAP‐treated patients in Turkey.Materials and Methods: The present study included 67 (52 male) consecutive OSA patients treated witha PAP device. Each subject underwent overnight full‐laboratory polysomnographic examination. The SF‐36 scores of patients given a PAP device were measured before they commenced using the device and 6–18months later. Results: Appropriate use of PAP devices improved quality of life as evidenced by improvement on allparameters of the SF‐36 instrument quality‐of‐life scale (P

Özet

Amaç: Uyku apne sendromu obezite ve kardiyovasküler hastalıklar ile yakın ilişkilidir. Uyku apne sendromu, nörokognitif fonksiyonları ve yaşam kalitesini olumsuz etkiler. Uyku apne sendromunun tedavisinde positive airway pressure (PAP) cihazlarının kullanımı halen altın standarttır. Bu çalışmada ülkemizde PAP ile tedavi edilen uyku apne sendromu olgularında kısa form‐36 anketi ile yaşam kalitesindeki değişim ölçülmüştür. Materyal ve Metot: Çalışma PAP cihazı ile tedavi edilen 52’si erkek toplam 67 ardışık uyku apne sendromu hastası ile yapıldı. Bütün olgulara tüm gece uyku laboratuvarında polisomnografi yapıldı. SF‐36 skoru PAP cihazı kullanmadan önce ve sonrasındaki 6‐18 aylık süre içinde yapıldı. Bulgular: PAP cihazını uygun şekilde kullanan hastalarda SF‐36’nın bütün parametrelerinde düzelme olduğu saptandı (P

🔖

Cite This Article

KİRAZ, K., ÇETİNKAYA, E. A., BENLİ, A. R., ÇÖRTÜK, M., ZİTOUNİ, B. (2022). Effect of Positive Airway Pressure Treatment on the Life Quality of Patients with Sleep Apnea Syndrome. Ankara Medical Journal, Cilt: 16 - Sayı: 4, 347–353. https://ajindex.com/articles/442065

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S. The occurrence of sleep‐disordered breathing among middle‐aged adults. N Engl J Med 1993
  2. 328(17):1230‐5. Somers VK, Dyken ME, Clary MP, Abboud FM. Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest 1995
  3. 96(4):1897‐904. Shafazand S. Perioperative management of obstructive sleep apnea: ready for prime time? Cleve Clin J Med 2009
  4. 98‐103. Somers VK, White DP, Amin R, et al. Sleep apnea and cardiovascular disease: an American Heart Association/American College of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council on Cardiovascular Nursing. J Am Coll Cardiol 2008
  5. 52(8):686‐717. Bradley TD, Floras JS. Obstructive sleep apnoea and its cardiovascular consequences. The Lancet 2009
  6. 373(9657):82‐93. Flemons WW, Tsai W. Quality of life consequences of sleep‐disordered breathing. J Allergy Clin Immunol 1997
  7. 99(2):750‐6. Baldwin CM, Griffith KA, Nieto FJ, O'Connor GT, Walsleben JA, Redline S. The association of sleep‐disordered breathing and sleep symptoms with quality of life in the Sleep Heart Health Study. Sleep 2001
  8. 24(1):96‐105. Karkoulias K, Lykouras D, Sampsonas F, et al. The impact of obstructive sleep apnea syndrome severity on physical performance and mental health. The use of SF‐36 questionnaire in sleep apnea. Eur Rev Med Pharmacol Sci 2013
  9. 17(4):531‐6. Ware JE, Jr., Sherbourne CD. The MOS 36‐item short‐form health survey (SF‐36). I. Conceptual framework and item selection. Med Care 1992
  10. 30(6):473‐83. Kocyigit H, Aydemir O, Fisek G, Olmez N, Memis A. Validity and reliability of Turkish version of Short form 36: A study of a patients with romatoid disorder. J Drug Ther 1999
  11. 102‐6. Yurtlu S, Sariman N, Levent E, Soylu AC, Alparslan S, Saygi A. Short‐term positive airway pressure therapy response in obstructive sleep apnea patients: impact of treatment on the quality of life. Tuberk toraks 2012
  12. 60(4):327‐35. Siccoli MM, Pepperell JC, Kohler M, Craig SE, Davies RJ, Stradling JR. Effects of continuous positive airway pressure on quality of life in patients with moderate to severe obstructive sleep apnea: data from a randomized controlled trial. Sleep 2008
  13. 31(11):1551‐8. Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 1991
  14. 14(6):540‐5. Iber C, Ancoli‐Israel S, Chesson AL, Quan